Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce C Marshall

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
JAMA|October 2, 2003
Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trialLisa Saiman, Bruce C Marshall, Nicole Mayer-Hamblett, et al.
Thorax|May 12, 2018
Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftorLeona Bessonova, Nataliya Volkova, Mark Higgins, et al.
JAMA|May 6, 2010
Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trialLisa Saiman, Michael Anstead, Nicole Mayer-Hamblett, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 15, 2019
Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registriesNataliya Volkova, Kristin Moy, Jennifer Evans, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2021
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation TreatmentChristopher H Goss, Sonya L Heltshe, Natalie E West, et al.
Thorax|June 10, 2011
Validation and use of a parametric model for projecting cystic fibrosis survivorship beyond observed data: a birth cohort analysisAbaigeal D Jackson, Leslie Daly, Andrew L Jackson, et al.
Learning Health Systems|September 21, 2023
The Cystic Fibrosis Learning Network: A mixed methods evaluation of program goals, attributes, and impactAricca D Van Citters, Madge E Buus-Frank, Joel R King, et al.
Chest|April 20, 2021
Survival and Lung Transplant Outcomes for Individuals With Advanced Cystic Fibrosis Lung Disease Living in the United States and Canada: An Analysis of National RegistriesKathleen J Ramos, Jenna Sykes, Sanja Stanojevic, et al.
Thorax|May 12, 2021
Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry dataDaniela K Schlüter, Josh S Ostrenga, Siobhán B Carr, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 2, 2023
Lung function decline is mitigated following liver transplantation in people with cystic fibrosis: A retrospective cohort studyFaisal A Albaiz, Kathleen J Ramos, Jenna Sykes, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
JAMA|October 2, 2003
Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trialLisa Saiman, Bruce C Marshall, Nicole Mayer-Hamblett, et al.
Thorax|May 12, 2018
Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftorLeona Bessonova, Nataliya Volkova, Mark Higgins, et al.
JAMA|May 6, 2010
Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trialLisa Saiman, Michael Anstead, Nicole Mayer-Hamblett, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 15, 2019
Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registriesNataliya Volkova, Kristin Moy, Jennifer Evans, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2021
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation TreatmentChristopher H Goss, Sonya L Heltshe, Natalie E West, et al.
Thorax|June 10, 2011
Validation and use of a parametric model for projecting cystic fibrosis survivorship beyond observed data: a birth cohort analysisAbaigeal D Jackson, Leslie Daly, Andrew L Jackson, et al.
Learning Health Systems|September 21, 2023
The Cystic Fibrosis Learning Network: A mixed methods evaluation of program goals, attributes, and impactAricca D Van Citters, Madge E Buus-Frank, Joel R King, et al.
Chest|April 20, 2021
Survival and Lung Transplant Outcomes for Individuals With Advanced Cystic Fibrosis Lung Disease Living in the United States and Canada: An Analysis of National RegistriesKathleen J Ramos, Jenna Sykes, Sanja Stanojevic, et al.
Thorax|May 12, 2021
Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry dataDaniela K Schlüter, Josh S Ostrenga, Siobhán B Carr, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 2, 2023
Lung function decline is mitigated following liver transplantation in people with cystic fibrosis: A retrospective cohort studyFaisal A Albaiz, Kathleen J Ramos, Jenna Sykes, et al.
Pageof 10